Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
Lee B, Rhead W, Diaz GA, Scharschmidt BF, Mian A, Shchelochkov O, Marier JF, Beliveau M, Mauney J, Dickinson K, Martinez A, Gargosky S, Mokhtarani M, Berry SA. Lee B, et al. Among authors: gargosky s. Mol Genet Metab. 2010 Jul;100(3):221-8. doi: 10.1016/j.ymgme.2010.03.014. Epub 2010 Mar 23. Mol Genet Metab. 2010. PMID: 20382058 Free PMC article. Clinical Trial.
A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency.
Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond FB Jr, Gargosky SE, Nonoshita L, Rosenfeld RG. Guevara-Aguirre J, et al. Among authors: gargosky se. J Clin Endocrinol Metab. 1995 Apr;80(4):1393-8. doi: 10.1210/jcem.80.4.7536209. J Clin Endocrinol Metab. 1995. PMID: 7536209 Clinical Trial.
The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL, Rosenfeld RG. Gargosky SE, et al. J Clin Endocrinol Metab. 1993 Dec;77(6):1683-9. doi: 10.1210/jcem.77.6.7505289. J Clin Endocrinol Metab. 1993. PMID: 7505289
Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.
Spagnoli A, Gargosky SE, Spadoni GL, MacGillivray M, Oh Y, Boscherini B, Rosenfeld RG. Spagnoli A, et al. Among authors: gargosky se. J Clin Endocrinol Metab. 1995 Dec;80(12):3668-76. doi: 10.1210/jcem.80.12.8530618. J Clin Endocrinol Metab. 1995. PMID: 8530618
Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG. Guevara-Aguirre J, et al. Among authors: gargosky se. J Clin Endocrinol Metab. 1997 Feb;82(2):629-33. doi: 10.1210/jcem.82.2.3743. J Clin Endocrinol Metab. 1997. PMID: 9024266 Clinical Trial.
Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
Labarta JI, Gargosky SE, Simpson DM, Lee PD, Argente J, Guevara-Aguirre J, Rosenfeld RG. Labarta JI, et al. Among authors: gargosky se. Clin Endocrinol (Oxf). 1997 Dec;47(6):657-66. doi: 10.1046/j.1365-2265.1997.2581078.x. Clin Endocrinol (Oxf). 1997. PMID: 9497872
62 results